Who Is This Event For?
The 4th ADC Linker & Conjugation Summit is designed for teams developing ADCs, bioconjugates, and next generation conjugate modalities who want to advance linker design, improve conjugation strategies, and build safer, more stable, manufacturable drugs.
Pharma Companies
Built for large pharma teams advancing complex ADC portfolios.
Why Attend:
- Benchmark linker and conjugation strategy with leaders across the ADC landscape
- Learn how to reduce instability, aggregation, and premature payload release
- Understand evolving CMC and regulatory expectations
- Gain practical insights to accelerate development toward IND and clinic
Relevant Job Functions:
- CMC & Process Development
- Medicinal & ADC Chemistry
- Toxicology, Safety, Regulatory CMC
Your Pharma Speakers:
ADC Novel Conjugate & Dual Payload Biotechs
Built for biotech teams developing next-generation ADC platforms, novel conjugation technologies, and multi-payload constructs.
Why Attend:
- Benchmark linker and conjugation innovations with emerging leaders shaping the next wave of ADC design
- Discover strategies to enable high-DAR and dual-payload constructs while maintaining stability and manufacturability
- Explore next-generation linker architectures, payload classes, and orthogonal conjugation technologies
- Gain practical insights to overcome hydrophobicity, aggregation, and payload compatibility challenges
Relevant Job Functions:
- Linker, Payload & Medicinal Chemistry
- Bioconjugation & Protein Engineering
- Discovery, Preclinical & Translational R&D
- CMC, Process Development & Technical Operations
Your Biotech Speakers:
Academic & Research Institutions
Built for academic scientists advancing fundamental research in linker chemistry, conjugation technologies, and next-generation ADC modalities.
Why Attend:
- Share cutting-edge research with industry leaders translating ADC innovation into the clinic
- Discover how emerging linker chemistries and conjugation strategies are shaping next-generation therapeutics
- Gain insight into translational challenges including stability, payload compatibility, and therapeutic index optimization
- Build collaborations with biotech and pharma teams seeking academic innovation and mechanistic expertise
Relevant Research Functions:
- Chemical Biology & Bioconjugation Research
- Medicinal Chemistry & Linker Design
- Protein Engineering & Molecular Engineering
- Translational, Preclinical & Mechanistic Research
Your Academic Speakers:
If your work touches linker design, conjugation chemistry, payload integration, stability optimization, or scaleup, this is the most focused and relevant meeting for your team.
Explore the Full Event Guide
The 4th ADC Linker & Conjugation Summit is the only dedicated platform focused solely on solving the chemistry challenges underpinning next-generation ADC design.
Highlights Include:
- 20+ expert speakers from leading big pharma and biotech organizations advancing linker and conjugation innovation
- Actionable, technical insights into site-specific, enzymatic, glycan-directed, click-chemistry, and pyridazinedione-based conjugation strategies
- Case studies on dual-payload ADCs, high-DAR constructs, degrader-antibody conjugates, and orthogonal conjugation platforms
- 2 interactive pre-conference workshops bridging chemistry with PK/PD and translational performance
